topSkip to main content

Menu, Secondary

Menu Trigger

Menu

New York's Leading Public Research Universities on the Forefront of Education and Innovation

New York’s leading public research universities are on the forefront of education and scientific innovation.


Only sixty-five years young, Stony Brook University is recognized as one of the nation’s top research universities, serving as a powerful engine for economic development, technological innovation and clinical care. SBU is not only transforming lives by revolutionizing cancer prognosis and advancing life-saving technologies for cardiac patients but also by offering a world-class education to students from all socio-economic backgrounds, providing them unmatched social and economic mobility.

The University at Buffalo was recognized as a research powerhouse back in 1989, when it became the first public university in New York invited to join the AAU, and its impact has only grown over the years. From developing new ways to treat memory loss in Alzheimer’s to pioneering minimally invasive surgical techniques, UB is making discoveries that lead to longer, healthier lives.

Learn more about the amazing work happening every day at New York's flagship public research universities:

A University at Buffalo sociologist is part of a research team whose new study is adding critical nuance toward better understanding the association between breastfeeding and infant health in the first year of life.
An investigation of more than 4,000 lung cancer patients reveals that patients treated under a multidisciplinary model of care have significantly higher survival rates compared to patients treated with a standard or traditional model of care. 
A new study from the University at Buffalo has shown that the presence of new or worsened bedsores is an effective indicator of the quality of care for rehab patients.
“Underwater wind farms” could generate low-cost, renewable energy from turbines placed in sandy river bottoms, researchers have found.
An international team of scientists demonstrated that genetically manipulating and removing the most common mutant form of the gene that promotes colorectal cancer in humans reduces tumor growth and tissue invasion.